Neuromuscular Disorders Treatment Market: Overview

Neuromuscular disorders encompass several diseases, divided in terms of localization into disorders that involve cranial and spinal motor neurons, peripheral nerves, nerve plexuses, spinal nerve roots, neuromuscular junctions, and/or muscles. Neuromuscular disorders affect the nerves that control voluntary muscles. When the neurons become unhealthy or die, communication between the nervous system and muscles breaks down. Consequently, muscles weaken and waste away (atrophy). Some of the known causes include inherited disorders, hormonal disorders, and autoimmune disorders. Symptoms of neuromuscular disease vary according to the condition and may be mild, moderate, or life threatening. These disorders result in muscle weakness and fatigue that progresses over time. Some neuromuscular disorders have symptoms that begin in infancy, while others may appear in childhood or even adulthood. 

Neuromuscular Disorders Treatment Market: Key Trends

The global neuromuscular disorders treatment market is driven by increase in government initiatives to ensure early diagnosis, rise in awareness about genetic disorders, improvement in health care infrastructure, and surge in research and development activities. However, low awareness in developing countries, stringent regulations, and lack of diagnostic facilities are projected to restrain the global neuromuscular disorders treatment market during the forecast period. A study conducted in 2014 indicated that prevalence rate of neuromuscular disorders was between 1 and 10 per 100,000, except for multifocal motor neuropathy, Lambert-Eaton myasthenic syndrome, Emery-Dreifuss dystrophy, oculopharyngeal muscular dystrophy, and congenital muscular dystrophies, which was <1/100,000. Post-polio syndrome and Charcot-Marie-Tooth disease had prevalence of >10/100,000.

Diagnosis of neuromuscular disorders is performed through physical examination and certain diagnostic tests. In order to assess the condition of a patient, a physician runs a complete medical history assessment to determine if any family member had previously had symptoms of neuromuscular disorders. Currently, there is no cure for neuromuscular disorders. Research is being done on genetic therapies and new medications to develop a cure. These are lifelong disorders and cannot be cured completely, but can be managed to help individuals to maximize their capabilities.

Neuromuscular Disorders Treatment Market: Segmentation

The global neuromuscular disorders treatment market can be segmented based on disorder, diagnosis, end-user, and region. In terms of disorder, the market can be categorized into motor neuron diseases, neuropathies, neuromuscular junction disorders, and myopathies including muscular dystrophies. Based on diagnosis, the global neuromuscular disorders treatment market can be classified into genetic test, blood test, lumbar puncture, electromyography (EMG), MRI scan, nerve conduction studies, muscle biopsy, and genetic testing. In terms of end-user, the neuromuscular disorders treatment market can be divided into hospitals, specialty clinics, and ambulatory surgery centers. In term of revenue, the hospitals segment dominated the market in 2018.

Neuromuscular Disorders Treatment Market: Regional Analysis

The global neuromuscular disorders treatment market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period owing to increase in patient population, better health care infrastructure, and presence of major players in the region. Europe is anticipated to account for the second largest market share from 2019 to 2027. Increase in investment, strong collaboration among research institutes and private players, and high awareness are expected to boost the growth of the market in the region during the forecast period. The global neuromuscular disorders treatment market in Asia Pacific is likely to grow at a rapid pace owing to increase in population, high acceptance of new treatment methodologies, and improvement in health care infrastructure in countries such as India. Increase in focus of major players in these regions is anticipated to drive the market in Latin America and Middle East & Africa during the forecast period. However, low awareness acts as a major restraint of the market in these regions.

Neuromuscular Disorders Treatment Market: Competitive Landscape

Key players in the global neuromuscular disorders treatment market include Pfizer, Inc., F. Hoffmann-La Roche Ltd., UCB Pharma, Astellas Pharma, Inc., Novartis AG, Abbott Laboratories, Inc., and Sanofi.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.